Nuclear Medicine and Biology

Aims & Scope

Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers.

The importance of the target to an unmet clinical need should be the first consideration.

If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.

These multidisciplinary studies should validate the mechanism of localization whether the probe is based on binding to a receptor, enzyme, tumor antigen, or another well-defined target.

The studies should be aimed at evaluating how the chemical and radiopharmaceutical properties affect pharmacokinetics, pharmacodynamics, or therapeutic efficacy.

Ideally, the study would address the sensitivity of the probe to changes in disease or treatment, although studies validating mechanism alone are acceptable.

Radiopharmacy practice, addressing the issues of preparation, automation, quality control, dispensing, and regulations applicable to qualification and administration of radiopharmaceuticals to humans, is an important aspect of the developmental process, but only if the study has a significant impact on the field.

Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate provided that the specificity of labeled compound localization and therapeutic effect have been addressed.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3
2024	3.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.742

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	100

Journal Rank

Year	Value
2024	7515

Journal Citation Indicator

Year	Value
2024	616

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Efficient production of high specific activity 64Cu using a biomedical cyclotron

  Citation: 443

  Authors: Deborah W., Ruth E., Robert E., Laura A., William H., Cathy S., Carolyn J., Michael J.

• Anatomy of SUV

  Citation: 376

  Authors: (Henry) Sung-Cheng

• PET imaging with 89Zr: From radiochemistry to the clinic

  Citation: 364

  Authors: Melissa A., Brian M., Lynn C., Jason S.

• Standardized methods for the production of high specific-activity zirconium-89

  Citation: 349

  Authors: Jason P., Yiauchung, Jason S.

• Graphical analysis of PET data applied to reversible and irreversible tracers

  Citation: 334

  Authors: Jean

• Copper radionuclides and radiopharmaceuticals in nuclear medicine

  Citation: 325

  Authors: Philip J., Jason S., Jamal

• Serotonin-1A receptor imaging in recurrent depression: replication and literature review

  Citation: 316

  Authors: Wayne C., Michael E., Eydie L., Julie, Ellen, David J., Chester

• O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications

  Citation: 290

  Authors: Karl-Josef, Kurt, Matthias, Frank, Gabriele, Dagmar, Heinz H., Dirk

• FDG Accumulation and Tumor Biology

  Citation: 271

  Authors: E.K.J, M.J, J.H.M.B, V.R, M, B

• In vivo biodistribution and accumulation of 89Zr in mice

  Citation: 249

  Authors: Diane S., Thomas, Peter M.

---